• Home
  • Latest
  • Fortune 500
  • Finance
  • Tech
  • Leadership
  • Lifestyle
  • Rankings
  • Multimedia
Right Arrow Button IconLeft Arrow Button IconHome
Right Arrow Button Iconsanofi

sanofi

Page 3 of 6
Sanofi and GSK to restart trial of COVID-19 vaccine after delay
Health
Sanofi and GSK to restart trial of COVID-19 vaccine after delay
By Tim Loh, Suzi Ring and BloombergFebruary 22, 2021
In this photo illustration various medical syringes seen with Sanofi Pasteur company logo displayed on a screen in the background.
Health
GSK and Sanofi shares fall as the pharma giants delay COVID-19 vaccine until late 2021
By David MeyerDecember 11, 2020
For AstraZeneca’s COVID vaccine, less may be more—and that’s puzzling researchers
Health
For AstraZeneca’s COVID vaccine, less may be more—and that’s puzzling researchers
By Angelica LaVito, John Lauerman and BloombergNovember 25, 2020
AstraZeneca-Oxford COVID vaccine on track for year end, CEO Pascal Soriot says
Health
AstraZeneca-Oxford COVID vaccine on track for year end, CEO Pascal Soriot says
By Suzi Ring, James Paton and BloombergNovember 5, 2020
Leadership Next podcast with Sanofi CEO Paul Hudson.
Leadership
Sanofi CEO sees Big Pharma collaborating more even after a COVID vaccine is approved
By McKenna MooreOctober 27, 2020
Medical syringe is seen with 'covid-19' sign displayed on a screen in the background in this illustration photo taken in Poland on October 12, 2020.
Health
As COVID-19 numbers boom and markets tank, Europe’s leaders urge vaccine coordination
By David MeyerOctober 15, 2020
Investors send global stocks higher on vaccine hopes and stimulus goodies—but tech shares continue to lag
Newsletters
Investors send global stocks higher on vaccine hopes and stimulus goodies—but tech shares continue to lag
By Bernhard WarnerSeptember 3, 2020
Sanofi, GlaxoSmithKline reach multi-billion dollar deal with U.S. for coronavirus vaccine
Newsletters
Sanofi, GlaxoSmithKline reach multi-billion dollar deal with U.S. for coronavirus vaccine
By Sy MukherjeeJuly 31, 2020
U.S. pledges $2.1 billion for up to 600 million doses of Sanofi, GlaxoSmithKline vaccine
Health
U.S. pledges $2.1 billion for up to 600 million doses of Sanofi, GlaxoSmithKline vaccine
By James Paton and BloombergJuly 31, 2020
France’s Sanofi to sell stake in high-flying Regeneron to fund new drugs discoveries
Finance
France’s Sanofi to sell stake in high-flying Regeneron to fund new drugs discoveries
By James Paton, Riley Griffin and BloombergMay 26, 2020
British pharma giant AstraZeneca get $1 billion from the U.S. to make coronavirus vaccine
Health
British pharma giant AstraZeneca get $1 billion from the U.S. to make coronavirus vaccine
By John Lauerman and BloombergMay 21, 2020
Will COVID-19 change how Big Pharma does clinical trials?
Magazine
Will COVID-19 change how Big Pharma does clinical trials?
By Erika FryMay 15, 2020
‘Unacceptable:’ A new France-U.S. spat erupts over Sanofi’s coronavirus vaccine plans
Health
‘Unacceptable:’ A new France-U.S. spat erupts over Sanofi’s coronavirus vaccine plans
By Phil Serafino and BloombergMay 14, 2020
Sanofi will combine its experimental coronavirus vaccine with GlaxoSmithKline Plc’s adjuvant technology, which may allow more doses of a shot to be produced.
Health
Sanofi and GlaxoSmithKline are teaming up to develop a coronavirus vaccine
By James Paton, Suzi Ring and BloombergApril 14, 2020
Paul Hudson, chief executive officer of Sanofi, gestures as he speaks during a panel session on the sidelines of the China International Import Expo (CIIE) in Shanghai, China, on Tuesday, Nov. 5, 2019. The CIIE -- now in its second year -- is designed to showcase the countrys desire to shift its economy toward consumption by buying more foreign goods. Photographer: Qilai Shen/Bloomberg via Getty Images
Newsletters
Big pharma’s big chance
By Katherine Dunn and Alan MurrayApril 3, 2020
1
  • 1
  • 2
  • 3
  • 4
  • 5
6
Most Popular
Success
Mark Cuban says he has the solution to growing income inequality, and it's to reward every employee—from CEO to janitor—with company stockplaceholder alt text
By Sasha RogelbergJuly 20, 2026
Success
‘I want to die broke’: Billionaire philanthropist Denny Sanford dies after giving away $4 billionplaceholder alt text
By Sydney LakeJuly 20, 2026
AI
'Dr. Doom' Nouriel Roubini says we're headed for universal basic income or 'some form of socialism' as AI revolutionizes work—He calls that optimisticplaceholder alt text
By Jason MaJuly 18, 2026
Fortune Secondary Logo
Rankings
  • 100 Best Companies
  • Fortune 500
  • Global 500
  • Fortune 500 Europe
  • Most Powerful Women
  • World's Most Admired Companies
  • See All Rankings
  • Lists Calendar
Sections
  • Finance
  • Fortune Crypto
  • Features
  • Leadership
  • Health
  • Commentary
  • Success
  • Retail
  • Mpw
  • Tech
  • Lifestyle
  • CEO Initiative
  • Asia
  • Politics
  • Conferences
  • Europe
  • Newsletters
  • Personal Finance
  • Environment
  • Magazine
  • Education
Customer Support
  • Frequently Asked Questions
  • Customer Service Portal
  • Privacy Policy
  • Terms Of Use
  • Single Issues For Purchase
  • International Print
Commercial Services
  • Advertising
  • Fortune Brand Studio
  • Fortune Analytics
  • Fortune Conferences
  • Business Development
  • Group Subscriptions
About Us
  • About Us
  • Press Center
  • Work At Fortune
  • Terms And Conditions
  • Site Map
  • About Us
  • Press Center
  • Work At Fortune
  • Terms And Conditions
  • Site Map
  • Facebook icon
  • Twitter icon
  • LinkedIn icon
  • Instagram icon
  • TikTok icon
  • YouTube icon

© 2026 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and Privacy Notice | Do Not Sell/Share My Personal Information
FORTUNE is a trademark of Fortune Media IP Limited, registered in the U.S. and other countries. FORTUNE may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.